From: Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
WHO grades
IDH1 mutation
IDH1 wild type
A II
4%
0%
A III
8%
14%
GBM
6%
36%
O II
13%
1%
O III
15%
3%